A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Rain Therapeutics, Inc.
Start Date
February 7, 2022
End Date
February 28, 2027
Administered By
Duke Cancer Institute
Awarded By
Rain Therapeutics, Inc.
Start Date
February 7, 2022
End Date
February 28, 2027